1 / 6

ELISpot and Fluorospot Assay Market Analysis, Cost Structures, Market Status and Forecasts to 2026

The increasing prevalence of chronic disorders, increasing technological advancements in the assay kits and analyzers, and increasing research in the field of vaccines are expected to be the primary factors affecting the market. <br><br>

Ptsoniya
Download Presentation

ELISpot and Fluorospot Assay Market Analysis, Cost Structures, Market Status and Forecasts to 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ELISpot and Fluorospot Assay Market To Reach USD 408.8 Million By 2026

  2. Market Summary The increasing prevalence of chronic disorders, increasing technological advancements in the assay kits and analyzers, and increasing research in the field of vaccines are expected to be the primary factors affecting the market. ELISpot and FluorospotAssay Market Size – USD 123.5 Million in 2018, Market Growth - CAGR of 15.9%, Market Trends–The increasing advancements in the field of diagnostics and cancer research could be some factors responsible for market growth

  3. Our Approach Our Approach Market Summary According to the current analysis of Reports and Data, the ELISpot and FluorospotAssay Market was valued at USD 123.5 million in 2018 and is expected to reach USD 408.8 million by the year 2026, at a CAGR of 15.9%. ELISpot, also known as Enzyme-linked immune absorbent spot and Fluorospot, are assay methods used to detect cytokine secretion in samples, including blood plasma, serum, tissues, and others. The technique is antibody-based, wherein the microplates used in the assay are covered by specific antibodies that detect significant proteins from the sample. The ELISpot and Fluorospotare used on a regular basis in various research institutes for cytokine detection and analysis secreted by single cells. The rise in the research and development in the vaccines sector is expected to drive the market majorly. Rising prevalence of infectious diseases that can be detected using ELISpot and Fluorospotassay methods is also a driving factor for the market. For instance, according to the estimates given by the World Health Organization (WHO), around 30 new diseases have emerged in the last 20 years, and now these diseases threaten the health of millions of people in the world. Moreover, the epidemics of infectious diseases worldwide affect around 3 to 5 million people annually and cause severe illness. Various companies have invested in the R&D sector to improve the assay techniques and to gain reliable results. The major players in the market include Oxford Immunotec, Cellular Technologies, Mabtech, Becton, Dickinson and Company, Abcam, Bio-Techne, U-CytechBiosciences, LophiusBiosciences GmbH, and Biotech InvestissementGroup. To Get Sample Copy of Report visit: https://www.reportsanddata.com/sample-enquiry-form/2697

  4. Our Approach Our Approach Market Summary By Product (Revenue in Million USD; 2016–2026) • Assay Kits • B cell assay • T cell assay • Ancillary products • Analyzers By Application (Revenue in Million USD; 2016–2026) • Cancer • Diagnostics • Transplants • Infectious diseases • Vaccines • Clinical trials • Others Click here to avail the report at an unbelievable discount rate @ https://www.reportsanddata.com/discount-enquiry-form/2697

  5. Our Approach Our Approach Market Summary Further key findings from the report suggest Different companies continue to be leaders since the introduction of ELISpot and Fluorospotassay techniques. For instance, Oxford Immunotechis the leading company in the market. The company has established itself across the globe and used various strategies to improve its presence in the market • The analyzers segment is widely driven due to the company called Cellular Technology Limited (CTL), which is the first company to introduce analyzers in ELISpot in the market. It has been a leading player in the industry since then. • Many technological advancements have led the market toward growth. For instance, in 2018, Mabtech launched an analyzer called IRIS analyzer, which is a 4-color fluorospotand ELISpot reader. • Also, in 2018, in the assay kits sector, Mabtechintroduced a human IL3 ELISpot kit. Such advancements continue the growth of the company in the market…Continued • Read More @ https://www.reportsanddata.com/report-detail/elispot-and-fluorospot-assay-market

  6. Our Approach Our Approach About Us About Us Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com

More Related